Fimepinostat in Treating Brain Tumors in Children and Young Adults

Clinical trial NCT03893487 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03893487
Sponsor: Sabine Mueller, MD, PhD
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Recurrent Anaplastic Astrocytoma Recurrent Glioblastoma Recurrent Malignant Glioma Recurrent Medulloblastoma

Start date: 2019-08-07
Primary completion: 2022-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.